SCOTT SULLIVAN: Open Payments
NPI 1750440004 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 13 payments from 10 companies in 2025. Trend: 2023 $355 · 2024 $401 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 4 | $79 |
| Dexcom, Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| Amgen Inc. | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $13 |
Products named: YUPELRI, Dexcom G6 Transmitter, Ozempic, INSPIRE, VIBERZI, NEXLETOL, Leqembi, LEQVIO.
Industry payments across FL — which companies pay providers there.
